Voici la liste des publications majeures de l'année 2000 :

Publications dans des revues internationales et nationales à comité de lecture

AGOSTINI D, BELIN A, HENRY-AMAR M, DARLAS Y, HAMON M, GROLLIER G, POTIER JC, BOUVARD G.
Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG scintigraphic study.
J Nucl Med 2000;41(5):845-51. [consulter le résumé]

ANISIMOV VN, ZABEZHINSKI MA, POPOVICH IG, ZARIPOVA EA, MUSATOV SA, ANDRE V, VIGREUX C, GODARD T, SICHEL F.
Inhibitory effect of melatonin on 7, 12-dimethylbenz[a]anthracene-induced carcinogenesis of the uterine cervix and vagina in mice and mutagenesis in vitro.
Cancer Lett 2000;156(2):199-205. [consulter le résumé]

BAUDIN B.
Angiotensin I-converting enzyme gene polymorphism and drug response.
Clin Chem Lab Med 2000;38(9):853-6. [consulter le résumé]

CHANEL S, BURKE L, FICHE M, MOLINA T, LE ROCHAIS JP, ICARD P, GALATEAU F.
BALT lymphoma and peripheral adenocarcinoma of lung.
Human Pathol 2000;201:622-23.

COLONNA M, HÉDELIN G, ESTÈVE J, GROSCLAUDE P, LAUNOY G, BUÉMI A, ARVEUX P, TRÉTARRE B, CHAPLAIN G, MACÉ-LESEC'H J, RAVERDY N, CARLI PM, MÉNÉGOZ F, FAIVRE J.
National cancer prevalence estimation in France.
Int J Cancer 2000;87:301-4. [consulter le résumé]

DELCAMBRE C, REMAN O, HENRY-AMAR M, PENY AM, MACRO M, CHEZE S, GENOT JY, TANGUY A, SWITSERS O, LY VH, COUETTE JE, LEPORRIER M, BARDET S.
Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy.
Eur J Nucl Med 2000;27(2):176-84. [consulter le résumé]

DENOUX Y, HERLIN P, MICHELS JJ, DE RANIERI J, GALLARD JC, CHASLE J.
Leiomyome à cellules bizarres de la prostate: un nouveau cas avec étude cytométrique.
Ann Urol (Paris) 2000;34(4):266-70. [consulter le résumé]

DENOUX Y, BOUTE V, CROUET H, CHANEL S, MARIE B, CHASLE J.
Léiomyome du mamelon : une lésion bénigne peu évolutive.
Sein 2000;10(3):185-7.

DUIGOU F, HERLIN P, MARNAY J, MICHELS JJ.
Variation of flow cytometric DNA measurement in 1,485 primary breast carcinomas according to guidelines for DNA histogram interpretation.
Cytometry 2000;42(1):35-42. [consulter le résumé]

HASBI A, ALLOUCHE S, SICHEL F, STANASILA L, MASSOTTE D, LANDEMORE G, POLASTRON J, JAUZAC P.
Internalization and recycling of delta-opioid receptor are dependent on a phosphorylation-dephosphorylation mechanism.
J Pharmacol Exp Ther 2000;293(1):237-47. [consulter le résumé]

JOLY F, ESPIE M, MARTY M, HERON JF, HENRY-AMAR M.
Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy.
Br J Cancer 2000;83(5):577-82. [consulter le résumé]

JOLY F, HERON JF, KERBRAT P, CHAUVERGNE J, RIOS M, MAYER F, CHINET-CHARROT P, GOUPIL A, LEBRUN-JEZEKOVA D, VENNIN D, LHOMME C, MACE-LESEC'H J, CROUET H.
High-dose platinum versus standard dose in advanced ovarian carcinoma: a randomized trial from the Gynecologic Cooperative Group of the French Comprehensive Cancer Centers (FNCLCC).
Gynecol Oncol 2000;78(3 Pt 1):361-8. [consulter le résumé]

LE PENNEC A, LACROIX J, FOURNIER LS, SCHMUTZ GR, BOUTE V, CROUET H, DENOUX Y.
La mammographie est-elle utile dans la maladie de Paget du sein?.
J Gynecol Obstet Biol Reprod (Paris) 2000;29(7):655-61. [consulter le résumé]

LINCET H, POULAIN L, REMY JS, DESLANDES E, DUIGOU F, GAUDUCHON P, STAEDEL C.
The p21(cip1/waf1) cyclin-dependent kinase inhibitor enhances the cytotoxic effect of cisplatin in human ovarian carcinoma cells.
Cancer Lett 2000;161(1):17-26. [consulter le résumé]

MANDARD AM, DENOUX Y, HERLIN P, DUIGOU F, VAN DE VIJVER MJ, CLAHSEN PC, VAN DEN BROEK L, SAHMOUD TM, HENRY-AMAR M, VAN DE VELDE CJ.
Prognostic value of DNA cytometry in 281 premenopausal patients with lymph node negative breast carcinoma randomized in a control trial: multivariate analysis with Ki-67 index, mitotic count, and microvessel density.
Cancer 2000;89(8):1748-57. [consulter le résumé]

MICHELS JJ, DUIGOU F, MARNAY J.
Flow cytometry in primary breast carcinomas. Prognostic impact of proliferative activity.
Breast Cancer Res Treat 2000;62(2):117-26. [consulter le résumé]

MOINET-HEDIN V, TABKA T, POULAIN L, GODARD T, LECHEVREL M, SATURNINO C, LANCELOT JC, LE TALAER JY, GAUDUCHON P.
Biological properties of 5,11-dimethyl-6H-pyrido[3,2-b]carbazoles: a new class of potent antitumour drugs.
Anticancer Drug Des 2000;15(2):109-18. [consulter le résumé]

POULAIN L, ZILLER C, MULLER CD, ERBACHER P, BETTINGER T, RODIER JF, BEHR JP.
Ovarian carcinoma cells are effectively transfected by polyethylenimine (PEI) derivatives.
Cancer Gene Ther 2000;7(4):644-52. [consulter le résumé]

ROBERGE C, TRAN M, MASSOUD C, POIREE B, DUVAL N, DAMECOUR E, FROUT D, MALVY D, JOLY F, LEBAILLY P, HENRY-AMAR M.
Quality of life and home enteral tube feeding: a French prospective study in patients with head and neck or oesophageal cancer.
Br J Cancer 2000;82(2):263-9. [consulter le résumé]

VAURS-BARRIERE C, PENAULT-LORCA F, LAPLACE-MARIEZE V, PRESNEAU N, MAUGARD CM, FICHE M, HARDOUIN A, BIGNON YJ.
Low frequency of microsatellite instability in BRCA1 mutated breast tumours.
J Med Genet 2000;37(10):E32.